GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blau Farmaceutica SA (BSP:BLAU3) » Definitions » EV-to-FCF

Blau Farmaceutica (BSP:BLAU3) EV-to-FCF : 11.12 (As of Dec. 11, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Blau Farmaceutica EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Blau Farmaceutica's Enterprise Value is R$2,639 Mil. Blau Farmaceutica's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was R$237 Mil. Therefore, Blau Farmaceutica's EV-to-FCF for today is 11.12.

The historical rank and industry rank for Blau Farmaceutica's EV-to-FCF or its related term are showing as below:

BSP:BLAU3' s EV-to-FCF Range Over the Past 10 Years
Min: -728.83   Med: 17.65   Max: 867.53
Current: 11.12

During the past 8 years, the highest EV-to-FCF of Blau Farmaceutica was 867.53. The lowest was -728.83. And the median was 17.65.

BSP:BLAU3's EV-to-FCF is ranked better than
78.12% of 553 companies
in the Drug Manufacturers industry
Industry Median: 25.77 vs BSP:BLAU3: 11.12

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-11), Blau Farmaceutica's stock price is R$14.19. Blau Farmaceutica's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was R$1.060. Therefore, Blau Farmaceutica's PE Ratio (TTM) for today is 13.39.


Blau Farmaceutica EV-to-FCF Historical Data

The historical data trend for Blau Farmaceutica's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blau Farmaceutica EV-to-FCF Chart

Blau Farmaceutica Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial - - -253.18 32.32 29.46

Blau Farmaceutica Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.81 29.46 13.73 13.47 10.32

Competitive Comparison of Blau Farmaceutica's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Blau Farmaceutica's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Blau Farmaceutica's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Blau Farmaceutica's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Blau Farmaceutica's EV-to-FCF falls into.



Blau Farmaceutica EV-to-FCF Calculation

Blau Farmaceutica's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2638.856/237.311
=11.12

Blau Farmaceutica's current Enterprise Value is R$2,639 Mil.
Blau Farmaceutica's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$237 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Blau Farmaceutica  (BSP:BLAU3) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Blau Farmaceutica's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=14.19/1.060
=13.39

Blau Farmaceutica's share price for today is R$14.19.
Blau Farmaceutica's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$1.060.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Blau Farmaceutica EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Blau Farmaceutica's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Blau Farmaceutica Business Description

Traded in Other Exchanges
N/A
Address
Rodovia Raposo Tavares, No. 2833, Km 30.5, Barro Branco, Cotia, SP, BRA, 06705-030
Blau Farmaceutica SA is engaged in the manufacturing, development and commercialization of complex private-label drugs for the institutional segment. The Company's business activities cover institutional and retail segments, and are divided into four units: 1) Biologicals are a heterogeneous class of products that can be produced using raw materials from biological materials and biotechnological procedures. 2) Oncology line is made up of oral and injectable drugs intended for treating cancer, which encompasses a number of therapeutic classes. 3) Specialties line is made up of products that are used in the hospital's daily routine, in the specialized treatments for infectious diseases and special treatments. 4) Others consist of prescription and non-prescription over-the-counter drugs.

Blau Farmaceutica Headlines

No Headlines